QDEL

QuidelOrtho Corporation

$11.52

-4.71%
SectorHealthcareIndustryMedical DevicesCountryUnited States

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, to measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases.

Source: Yahoo Finance
AI summary

Price & performance

1M+5.8%
3M-26.6%
YTD-55.4%
1Y-53.1%
52-week range—
Beta1.64
Full chart and returns against a benchmark

Q-Score

43/ 100

Quality against peers; 50 is the peer median.

Growth32
Risk47
Performance32
Valuation67
Profitability56
Leverage37
Sentiment8
Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue$2.7B-1.9%
Net income-$1.1B
Net margin-41.5%+32.3 pts
Historical fundamentals

Red flags in filings

1active red flag
Auditor changeMar 4, 2025
Filings, findings and the timeline

Revenue exposure

Domestic Country53%
Foreign Country47%
Largest customer11%
Regions, segments, customers and suppliers

Valuation

QDELIndustryP/E—29.61P/S0.303.49EV/EBITDA10.6518.38P/B0.443.39PEG——
Dividend yield0.00%
Every valuation metric

Earnings

Nov 3next report
EPS estimate$0.18
Beats (last 4 quarters)—
Average surprise—
EPS revisions (30d)—
Every quarter against its estimate